Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

By Xiao-Hui Zhang, L. Tee, Xiaogang Wang, Qunshan Huang, Shihua Yang. Molecular Therapy: Nucleic Acids, 2015

1,125 citations recorded by the source corpus.

CRISPR/Cas9 is a versatile genome-editing technology that is widely used for studying the functionality of genetic elements, creating genetically modified organisms as well as preclinical research of genetic disorders. However, the high frequency of off-target activity (≥50%)—RGEN (RNA-guided endonuclease)-induced mutations at sites other than the intended on-target site—is one major concern, especially for therapeutic and clinical applications. Here, we review the basic mechanisms underlying off-target cutting in the CRISPR/Cas9 system, methods for detecting off-target mutations, and strategies for minimizing off-target cleavage. The improvement off-target specificity in the CRISPR/Cas9 system will provide solid genotype–phenotype correlations, and thus enable faithful interpretation of genome-editing data, which will certainly facilitate the basic and clinical application of this technology.

Subfields: Aging, Business and International Management, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/ade6d1a34ce18c333f531bf430118c5963a2f260